Amorphous solid dispersions have gained tremendous attention as a commercially viable solubility enhancement technique for poorly water-soluble drugs. However, poor drug loading associated with drug-polymer miscibility is major challenge in the downstream processing of ASDs. While many techniques are available converting ASDs into final dosage forms, oral solids remain most viable. The type exc...